ASIA VITAL COMPONENTS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 638 TWD | -2.45% |
|
-3.63% | +89.60% |
| Mar. 18 | Asia Vital Components Co., Ltd.(TWSE:3017) added to FTSE All-World Index | CI |
| Mar. 13 | Asia Vital Components Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 14,715 | 23,354 | 31,162 | 39,571 | 128,984 | 244,552 | - | - |
| Enterprise Value (EV) 1 | 14,715 | 18,995 | 26,976 | 30,814 | 114,987 | 224,390 | 217,665 | 209,696 |
| P/E ratio | - | - | - | - | 23.8 x | 32.9 x | 23.3 x | 17.8 x |
| Yield | - | 4.24% | 3.74% | 4.04% | 2.08% | 1.16% | 1.9% | 2.28% |
| Capitalization / Revenue | 0.4 x | 0.59 x | 0.66 x | 0.71 x | 2.18 x | 3.46 x | 2.7 x | 2.28 x |
| EV / Revenue | 0.4 x | 0.48 x | 0.57 x | 0.55 x | 1.94 x | 3.17 x | 2.4 x | 1.95 x |
| EV / EBITDA | - | 4.22 x | 4.21 x | 3.84 x | 12.3 x | 16.9 x | 11.9 x | 9.26 x |
| EV / FCF | - | 7.72 x | 20.7 x | 5.92 x | 17.2 x | 35.9 x | 20.3 x | 17.4 x |
| FCF Yield | - | 13% | 4.82% | 16.9% | 5.8% | 2.79% | 4.92% | 5.75% |
| Price to Book | - | 2.21 x | 2.51 x | 2.55 x | 5.86 x | 8.61 x | 7.05 x | 5.51 x |
| Nbr of stocks (in thousands) | 353,310 | 353,310 | 353,310 | 353,310 | 383,310 | 383,310 | - | - |
| Reference price 2 | 41.65 | 66.10 | 88.20 | 112.0 | 336.5 | 638.0 | 638.0 | 638.0 |
| Announcement Date | 3/12/20 | 3/22/21 | 3/18/22 | 3/13/23 | 3/13/24 | - | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 36,534 | 39,666 | 47,333 | 56,017 | 59,194 | 70,703 | 90,660 | 107,397 |
| EBITDA 1 | - | 4,496 | 6,404 | 8,021 | 9,375 | 13,288 | 18,255 | 22,643 |
| EBIT 1 | 1,259 | 3,260 | 4,827 | 6,306 | 7,421 | 10,747 | 15,781 | 20,164 |
| Operating Margin | 3.45% | 8.22% | 10.2% | 11.26% | 12.54% | 15.2% | 17.41% | 18.78% |
| Earnings before Tax (EBT) 1 | - | - | - | - | 8,025 | 11,805 | 16,101 | 19,642 |
| Net income 1 | - | - | - | - | 5,305 | 7,424 | 10,478 | 13,722 |
| Net margin | - | - | - | - | 8.96% | 10.5% | 11.56% | 12.78% |
| EPS 2 | - | - | - | - | 14.11 | 19.37 | 27.34 | 35.80 |
| Free Cash Flow 1 | - | 2,462 | 1,301 | 5,204 | 6,667 | 6,257 | 10,718 | 12,066 |
| FCF margin | - | 6.21% | 2.75% | 9.29% | 11.26% | 8.85% | 11.82% | 11.23% |
| FCF Conversion (EBITDA) | - | 54.76% | 20.32% | 64.88% | 71.11% | 47.09% | 58.71% | 53.29% |
| FCF Conversion (Net income) | - | - | - | - | 125.68% | 84.28% | 102.28% | 87.93% |
| Dividend per Share 2 | - | 2.800 | 3.300 | 4.520 | 7.000 | 7.429 | 12.11 | 14.53 |
| Announcement Date | 3/12/20 | 3/22/21 | 3/18/22 | 3/13/23 | 3/13/24 | - | - | - |
1TWD in Million2TWD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 12,593 | 13,764 | 14,883 | 14,777 | 11,835 | 14,871 | 15,769 | 16,720 | 15,309 | 16,038 | 18,292 | 19,977 | 18,338 |
| EBITDA 1 | - | - | - | - | - | - | - | 2,949 | 2,492 | 3,182 | 3,809 | 4,507 | - |
| EBIT 1 | 1,336 | 1,528 | 1,756 | 1,686 | 1,352 | 1,547 | 2,105 | 2,416 | 1,935 | 2,246 | 2,790 | 3,260 | 2,892 |
| Operating Margin | 10.61% | 11.1% | 11.8% | 11.41% | 11.43% | 10.41% | 13.35% | 14.45% | 12.64% | 14% | 15.25% | 16.32% | 15.77% |
| Earnings before Tax (EBT) 1 | - | - | - | - | - | - | 2,220 | 2,491 | 2,330 | 2,356 | 2,852 | 3,269 | 3,321 |
| Net income 1 | - | - | - | - | - | - | 1,426 | 1,671 | 1,564 | 1,546 | 1,882 | 2,170 | 2,278 |
| Net margin | - | - | - | - | - | - | 9.04% | 9.99% | 10.22% | 9.64% | 10.29% | 10.86% | 12.42% |
| EPS 2 | - | - | - | - | - | - | 3.720 | 4.360 | 4.080 | 4.165 | 5.240 | 5.982 | 5.739 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 5/11/22 | 8/9/22 | 11/11/22 | 3/13/23 | 5/10/23 | 8/9/23 | 11/10/23 | 3/13/24 | 5/10/24 | - | - | - | - |
1TWD in Million2TWD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | 4,358 | 4,185 | 8,757 | 13,997 | 20,161 | 26,886 | 34,856 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | 2,462 | 1,301 | 5,204 | 6,667 | 6,257 | 10,718 | 12,066 |
| ROE (net income / shareholders' equity) | - | 19.6% | 25.2% | 29.8% | 28.3% | 28.6% | 33.5% | 34.3% |
| ROA (Net income/ Total Assets) | - | 5.03% | - | - | 8.03% | 10.6% | 14.4% | 19.9% |
| Assets 1 | - | - | - | - | 66,070 | 70,016 | 72,805 | 68,903 |
| Book Value Per Share 2 | - | 29.90 | 35.10 | 43.90 | 57.50 | 74.10 | 90.40 | 116.0 |
| Cash Flow per Share 2 | - | - | - | - | 26.70 | 19.80 | 28.80 | 61.50 |
| Capex 1 | - | 2,407 | 1,540 | 3,636 | 3,657 | 3,555 | 3,268 | 2,500 |
| Capex / Sales | - | 6.07% | 3.25% | 6.49% | 6.18% | 5.03% | 3.6% | 2.33% |
| Announcement Date | 3/12/20 | 3/22/21 | 3/18/22 | 3/13/23 | 3/13/24 | - | - | - |
1TWD in Million2TWD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
638
TWD
Average target price
768.7
TWD
Spread / Average Target
+20.48%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +89.60% | 7.53B | |
| +73.56% | 94.77B | |
| -1.23% | 29.08B | |
| +0.47% | 22.18B | |
| +10.12% | 19.74B | |
| -7.33% | 16.07B | |
| -3.44% | 13.07B | |
| -3.88% | 10.77B | |
| +12.94% | 10.38B | |
| +15.62% | 10.08B |
- Stock Market
- Equities
- 3017 Stock
- Financials Asia Vital Components Co., Ltd.